Some of the available monoclonal antibodies to treat migraine include erenumab, fremanezumab, galcanezumab, and eptinezumab.

Inside Charlie's Places for People home A mum from Preston has spoken out after problems in her home that she says have left ...

But research shows that different seed oils have varying effects on risk for heart disease. Furthermore, seed oils have also been shown to increase risk for migraines. This is likely due to their high ...

Sama Daga comes from a family of distinguished debaters. But struggling with chronic migraines, she realized something had to give.

Healthcare workers say there are multiple treatment options available for migraines, but the best approach depends on the individual's preferences and the frequency of their headaches.

In today's Women's Health Wednesday, we talked about migraines. Adult women are affected three times more often than men, ...

Erenumab significantly improved quality of life and disability among patients with chronic and episodic migraine over a 2-year period.

Axsome Therapeutics introduces Symbravo in US for acute treatment of migraine with or without aura in adults: New York Wednesday, June 11, 2025, 16:00 Hrs [IST] Axsome Therapeutic ...